Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × INDUSTRY × Alpelisib × Clear all

Phase

Phase 1 15 Phase 3 8 Phase 2 8 Phase 1/2 7 Phase 4 1 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Endocrine Neoplasia Type 1 1

Interventions

Zoledronic Acid 23 Bevacizumab 13 nilotinib 12 Docetaxel 12 Paclitaxel 11 Everolimus 11 Letrozole 10 Imatinib Mesylate 10 Capecitabine 10 Erlotinib Hydrochloride 9 Drug Therapy 9 Carboplatin 9 pegfilgrastim 8 enzalutamide 8 Trastuzumab 7 Oxycodone 7 Nivolumab 7 Imiquimod 7 Gemcitabine 7 Epoetin Alfa 7 icotinib 6 Rituximab 6 Prednisone 6 Pemetrexed 6 Oxaliplatin 6 Leuprolide 6 Fulvestrant 6 Diclofenac 6 Dexamethasone 6 Cisplatin 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05631795 2026-04-07

ALPINIST

Novartis

Phase 4 Completed

Multiple Endocrine Neoplasia Type 1

Data powered by HemOnc (CC BY 4.0) Colophon ⚡